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Despite the potential for infectious agents harbored by other species to become emerging human pathogens, little is
known about why some agents establish successful cross-species transmission, while others do not. The simian
immunodeficiency viruses (SIVs), certain variants of which gave rise to the human HIV-1 and HIV-2 epidemics, have
demonstrated tremendous success in infecting new host species, both simian and human. SIVsm from sooty
mangabeys appears to have infected humans on several occasions, and was readily transmitted to nonnatural Asian
macaque species, providing animal models of AIDS. Here we describe the first in-depth analysis of the tremendous
SIVsm quasispecies sequence variation harbored by individual sooty mangabeys, and how this diverse quasispecies
adapts to two different host species—new nonnatural rhesus macaque hosts and natural sooty mangabey hosts. Viral
adaptation to rhesus macaques was associated with the immediate amplification of a phylogenetically related subset
of envelope (env) variants. These variants contained a shorter variable region 1 loop and lacked two specific
glycosylation sites, which may be selected for during acute infection. In contrast, transfer of SIVsm to its natural host
did not subject the quasispecies to any significant selective pressures or bottleneck. After 100 d postinfection, variants
more closely representative of the source inoculum reemerged in the macaques. This study describes an approach for
elucidating how pathogens adapt to new host species, and highlights the particular importance of SIVsm env diversity
in enabling cross-species transmission. The replicative advantage of a subset of SIVsm variants in macaques may be
related to features of target cells or receptors that are specific to the new host environment, and may involve CD4-
independent engagement of a viral coreceptor conserved among primates.
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Introduction
At least 40 primate species in Africa are infected by diverse
simian immunodeﬁciency viruses (SIVs) assigned to six major
phylogenetic lineages; however, the mosaic nature of the SIV
genomes attests to the common simian-to-simian trans-
mission of SIVs [1,2]. These African nonhuman primate
reservoir hosts maintain normal CD4 T cell counts and avoid
AIDS, despite lifelong SIV infection [3–6]. Our studies of
naturally SIV-infected sooty mangabeys (SMs) indicate that
these hosts are highly viremic, yet manifest far lower levels of
aberrant immune activation and apoptosis than are seen in
pathogenic SIV and HIV infections; these latter observations
help to explain how SMs maintain numerically and function-
ally intact T lymphocyte populations [3]. Zoonotic trans-
mission and sustained propagation of SIVcpz and SIVsm
from SIV-infected chimpanzees and SMs, respectively, to
humans [2,7], resulted in the human HIV-1 and HIV-2 AIDS
epidemics.
SIV and HIV env sequence variation, including variation in
length and glycosylation patterns, enables these viruses to
utilize different coreceptors for infection, and to adapt to
variation in the relative levels of the viral receptor (CD4) and
coreceptors (e.g., CC-chemokine receptor 5 [CCR5]) to gain
efﬁcient entry into cells [8,9]. Env variation also enables the
virus to readily escape antibody responses [10–12]. Our
studies of SIVsm env diversity in naturally infected SMs
demonstrate high levels of intrahost env variable region 1 and
2 (V1V2) amino acid diversity (median, 5.6%; range, 0%–
38%) that are maintained by continual positive selection,
presumably antibody mediated (unpublished data). Consid-
erable V1V2 amino acid length variation and high and
variable numbers of glycosylation consensus sequences are
also observed. This high diversity of SIV V1V2 in the natural
host environment may promote the potential for cross-
species transmission by generating the env variants necessary
to ensure successful infection of new hosts.
For successful cross-species transmission to occur, includ-
ing the continued propagation of an infectious agent in a new
host species, the agent must be able to replicate at levels in
the new host that ensure its sustained passage to new
individuals of that species; otherwise the newly infected
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not lead to secondary and sustained infections in the new
species. Alternatively, the infectious agent that has been
recently transmitted to a new host may require the
accumulation of mutations that enable it to replicate at
levels high enough to ensure continued transmission to new
individuals. Thus, SIVs that are capable of quickly adapting to
new hosts and replicating to high levels are most likely to
successfully breach the species barrier and continue to spread
in the new species. Adaptation of naturally occurring SIV
quasispecies to new hosts has not been studied. In studies
analyzing the adaptation of diverse HIV-1 quasispecies from
identiﬁable human donors to newly infected ‘‘recipients,’’ the
early expansion of viruses that are homogeneous in env
sequences, macrophage-tropic, and CCR5-utilizing is de-
scribed [13,14]. This sequence homogenization is not
observed in gag [15], suggesting that multiple variants are
transmitted, followed by selection for particular env variants
during primary infection. Selection for env homogeneity has
also been reported after parenteral inoculation [13], suggest-
ing that, separate from any selective processes taking place at
the mucosal barrier, there is strong selection for particular
env genotypes during acute infection. Recently, a study of
heterosexual HIV-1 transmission demonstrated that viruses
encoding compact, glycan-restricted Envs with exposed
neutralizing epitopes were signiﬁcantly favored in newly
infected hosts [16]. Another report conﬁrmed these ﬁndings
in transmission of subtype A but not B [17]. Whether these
observations extend to other clades, cohorts, or routes of HIV
infection remains to be determined [18,19].
Here we describe the adaptation of diverse SIVsm
quasispecies to the new rhesus macaque (RM) host, and
compare quasispecies evolution in natural SM and non-
natural RM hosts. During the ﬁrst days of infection, SIVsm
replicated as well in the RM host as in the original host, if not
better, apparently due to the robust replicative capacity of a
subset of viral variants containing a shorter V1 loop and
lacking two speciﬁc glycosylation sites. This study demon-
strates how viral quasispecies diversity, by providing multiple
variants, some of which can replicate to high levels in new
hosts, may facilitate cross-species transmission.
Results
High Diversity of the SIVsm Quasispecies Inoculum
The uncloned SIVsm inoculum consisting of plasma from a
naturally infected SMs contained 4310
6 SIV RNA copies/ml.
To characterize the diversity of this source inoculum (SI), and
the molecular behavior of the quasispecies upon transmission
to new hosts, we analyzed a 456-nucleotide region spanning
the variable V1V2 region of env and a 421-nucleotide region
of the p27 capsid region of the more functionally conserved
gag gene (GenBank accession numbers AY852284–AY853166).
We chose to sequence only portions of the coding sequences
of these two genes, as efforts to amplify full-length coding
sequences resulted in poor RT-PCR ampliﬁcation efﬁciencies
that were not compatible with the reliable sampling of
multiple quasispecies variants. Sequences representing ac-
tively replicating SIV were ampliﬁed directly from virion
RNA in the plasma by RT-PCR. 29 V1V2 and 7 gag clone
sequences analyzed using maximum parsimony, neighbor-
joining (NJ), and maximum likelihood (ML) phylogenetic tree
constructions demonstrated that the SI was phylogenetically
distinct from commonly used laboratory SIV isolates (Figure
S1).
SI V1V2 sequence length varied between 139 and 143 aa
( T a b l e1 ) .T h er a n g eo fp a i r w i s en u c l e o t i d ed i v e r s i t y
calculated for the SI population was 0.3%–5.1% for V1V2
(mean, 2.7%; median, 2.7%) and 0.7%-4.6% for gag (mean,
2.4%; median, 2.3%). The amino acid diversity ranged from
0% to 12.8% in V1V2 (mean, 5.9%; median, 6.3%) with only
six of 406 identical pairwise comparisons. The amino acid
diversity in gag p27 was lower, ranging from 0% to 0.7%
(mean, 0.2%; median, 0%). The minimal diversity detected in
gag, which was PCR-ampliﬁed using identical conditions,
suggests that the observed V1V2 diversity is not the result of
PCR-introduced mutation. The average viral diversity ob-
Table 1. V1V2 Amnio Acid Variation in RMs and SMs at Days 10
and 14 and in SI
Variant Type SI Day 10 Day 14
RM1 RM2 SM1 SM2 RM1 RM2 RM3 SM1 SM2 SM3
Length
(aa)
143 0.03 0 0 0.05 0.00 0 0 0 0 0 0
142 0.38 0.05 0.05 0.60 0.29 0000.71 0.53 0.30
141 0.03 0 0.05 0.10 0.15 0 0 0 0.05 0.20 0.07
140 0.34 0.86 0.75 0.20 0.12 0.90 1.00 0.86 0.24 0.27 0.30
139 0.21 0.05 0.05 0.05 0 0.10 0 0.10 0 0 0.26
138 0 0.05 0.05 0 0 0 0 0.05 0 0 0.07
1 3 70 00 . 0 5 00000000
Glyco-
sylation
Glyc.
Pos. 7
0.52 0.05 0.05 0.80 0.44
00
0.05 0.71 0.73 0.74
Glyc.
Pos. 19
0.52 0.05 0 0.70 0.44 0 0 0.05 0.71 0.73 0.37
Shown are the frequencies within each set of sequences for each V1V2 amino acid length variant (137–143 aa) and
the frequencies of glycosylation at amino acid positions 7 and 19. The amino acid length present at the highest
frequency is underlined. For SI, the two amino acid lengths present at similarly high frequency are underlined and
highlighted, corresponding to those seen in RMs (blue) and SMs (red). Note the homogeneity and shorter length of
RM V1V2.
DOI: 10.1371/journal.ppat.0010003.t001
PLoS Pathogens | www.plospathogens.org September 2005 | Volume 1 | Issue 1 | e3 0030
SIV Adaptation to a New Host
Synopsis
Why do some infectious agents establish successful cross-species
transmission while others do not? Despite the clear potential for
diseases harbored by animals to become emerging human
pathogens, this question remains unanswered. Certain simian
immunodeficiency viruses (SIVs) responsible for the human HIV-1
and HIV-2 epidemics have succeeded in infecting new host species,
including humans. This study provides clues to how an SIV adapts to
a new host in an experimental cross-species transmission. Indeed,
many emerging diseases are caused by highly mutation-prone RNA
viruses like SIV, which exist not as a single species, but rather as a
population of genetic variants within a single infection. The
presence of numerous viral variants in an infected animal increases
the chance that variants with the ability to enter into or multiply in a
new host species are present. This study describes how an SIV
population from a natural reservoir host, the sooty mangabey,
adapts to a new monkey species, the rhesus macaque. A limited
subset of SIV variants containing unique viral surface proteins
appears well suited to multiply in the new host. This study
documents how viral variation facilitates cross-species transmission,
and highlights the particular importance of immunodeficiency virus
envelope variants in infecting new hosts.served in this study is similar to that reported in other studies
of SIV infections of natural hosts [4,20,21]. The within-host
extremes of V1V2 diversity observed in this and another
study (unpublished data) is a novel observation resulting from
the large number of sequences analyzed.
Robust Virus Replication Demonstrates Immediate
Quasispecies Adaptation to the New Nonnatural RM Host
SMs and RMs were intravenously (IV) inoculated with 1 ml
of the SI described above (SIVsm). IV injection may partially
recapitulate the circumstances of cross-species SIV trans-
mission, which are thought to involve exposure to bloody
ﬂesh during hunting or butchering [22,23]. It ensures
reproducible infection and enables the study of host-speciﬁc
differences in response to SIV infection that lead to AIDS in
RMs but not SMs [24]. At day 7 postinfection (p.i.), SIVsm
replication was detected in all animals except RM2 (Figure
S2). Peak viremia occurred between days 10 and 14 for all
animals except RM2, whose peak likely occurred between
days 14 and 28, an interval when no sampling was performed.
RM1 and RM3 manifested peak viremia levels of 1.6 3 10
9
copies/ml of plasma and 6.1 3 10
8 copies/ml respectively,
higher than the peak viremia for the three SMs (5.0 3 10
7 to
1.5 3 10
8 copies/ml). Viral loads declined to similar set point
levels of ;1 3 10
6 copies/ml, except for RM2, which
maintained fewer than 1,000 copies/ml after day 60. RM1
and RM3 developed AIDS 2.5 and 3.5 y p.i. and were
euthanized. Divergent host responses and disease outcomes
during primary SIVsm infection of SMs and RMs are
described elsewhere [24].
Early Amplification of a Phylogenetically Related Subset of
env Variants in RMs Contrasts with Unrestricted env
Diversity in SMs
At day 14 p.i., the replicating env V1V2 sequences for all six
animals were compared to each other and to the SI. Despite
the more robust replication of SIVsm in the RMs, few of the
SI V1V2 variants appeared among the clade containing most
of the variants replicating in RMs (clade 1; Figure 1),
demonstrating that a subset of genetically related env variants
w a sa m p l i ﬁ e dd u r i n ga c u t eS I V s mi n f e c t i o no fR M s .
Speciﬁcally, the proportion of variants replicating in RMs
in clade 1 (97%) was signiﬁcantly higher than that of either
the SI variants (21%; Marascuillo Procedure, p , 0.0001) or
the variants replicating in SMs (22%; p , 0.0001). In contrast,
there was little selection of speciﬁc SIVsm env variants upon
transfer to new naı ¨ve SMs, with no signiﬁcant difference
(Marascuillo Procedure, p ¼ 99%) in the distributions of SI
variants and variants replicating in SMs between clades 1 and
2 (Figure 1). Mean intrahost pairwise nucleotide diversity in
the RMs at day 14 was 0.9%, signiﬁcantly lower than that of
the SMs (2.1%; Tukey’s HSD, p , 0.05) and the SI (Newman-
Keuls, p , 0.05). Mean intrahost amino acid diversity in RMs
at day 14 (1.6%) was lower than SM amino acid diversity
Figure 1. Phylogenetic Tree of V1V2 Variants
An NJ tree of all day 14 and SI V1V2 variants, constructed using a GTR model of evolution. Bootstrap support values greater than 50% are shown in
italics at nodes and the number of multiple clones from the same animal at the ends of branches is indicated beside the symbol.
DOI: 10.1371/journal.ppat.0010003.g001
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SIV Adaptation to a New Host(3.4%), although not signiﬁcantly. This pattern of restriction
was observed as early as 10 d p.i., with 37/39 (95%) of RM
variants clustering with the same six SI variants seen at day 14
(unpublished data). Thus, only a subset of env genotypes
appear well suited to replicate in the new RM host environ-
ment, but this subset replicates to surprisingly high levels.
SIVsm env Variants That Are Preferentially Amplified in
Newly Infected RMs Contain Shorter V1 Regions and Lack
Two Glycosylation Consensus Sequences
SIV env glycosylation is important in receptor and
coreceptor utilization [25], and in evading neutralizing
antibodies [26,27]. Eight predicted N-linked glycosylation
sites (N-gly) containing the amino acid motif NXT/S were
identiﬁed along the 125 aa of V1V2 analyzed, although direct
evidence of glycosylation at these sites is not explicitly
demonstrated. Among the 29 SI clones analyzed, most of
these positions encoded the consensus N-gly sequence
(Figures 2 and S3), consistent with the observation that
SIVsm V1V2 is highly glycosylated in its natural host
(unpublished data).
Two of these predicted N-gly sites, at positions 7 and 19 in
V1 (Figure 2), were immediately selected against in the newly
infected RMs, before the anticipated development of an
antibody response. (RMs and SMs demonstrated anti-SIV
antibodies by ELISA at day 40 p.i., the ﬁrst time-point
assessed, with increasing titers by day 130 p.i. [unpublished
data]). In the SI, 76% and 52% of V1V2 sequences exhibited
the N-gly motif at positions 7 and 19. At 10 d p.i., the motif at
position 7 was present in 80% of SM1 sequences, but in only
Figure 2. Pattern and Temporal Dynamics of Protein Sequence Evolution in Envelope
V1V2 amino acid sequence for SI, SM1, and RM1 at days 10 and 578. The consensus of all sequences is indicated at the top with amino acid positions
labeled above. Glycosylation consensus motifs (NXT/S) are highlighted in yellow.
DOI: 10.1371/journal.ppat.0010003.g002
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in 70% of SM1 sequences compared to 5% of RM1 sequences
(Figure 2 for SM1 and RM1 at day 10; Table 1 for frequencies
in all animals). The near absence of the motif at positions 7
and 19 was observed in all RMs analyzed at days 10 and 14
(Figure S3). Furthermore, the predominant V1V2 variants in
RMs at days 10 and 14 were shorter in length by two amino
acids compared to the variants in SM (Table 1). Thus, a
disadvantage of variants with longer V1 loops and two
speciﬁc N-gly sites in V1 may explain the restricted out-
growth of speciﬁc env variants during early infection of RMs.
At days 10–100, SIVsm sequences from SMs had a greater
mean number of N-gly sites per sequence than variants in
RMs, but by day 578 the overall frequency of glycosylation
consensus motifs increased in both species, and there was no
difference between species (Figure S4; p , 0.001). This
increase in mean glycosylation over time in the RMs is in part
due to the reemergence of variants containing the two
speciﬁc N-gly sites that were absent in the majority of early
RM variants. The range of V1 region amino acid length
variations also increased over time, and no species-speciﬁc
differences were seen at day 100 and thereafter (unpublished
data). These data demonstrate continual evolution of V1 in
both SMs and RMs.
Increasing Positive Selection in SMs and RMs at Later
Times Postinfection
To compare selection pressures between hosts and time
points, nonsynonymous and synonymous nucleotide substi-
tutions (dN and dS, respectively) at each codon of V1V2 were
calculated for sequences at day 14 (prior to seroconversion)
and day 578 (chronic infection) for each animal and the SI
(Figure 3). The pattern of selection in SMs at both time points
(Figure 3A and 3B) was similar to the SI (Figure 3E),
suggesting few changes in selection pressure upon SIVsm
transfer to naı ¨ve SMs. This is consistent with the phylogenetic
analyses, which indicate that IV transfer of SIVsm does not
subject the quasispecies to any signiﬁcant selective pressures
or bottleneck in the natural SM host, but results in
considerable restriction of the SIVsm quasispecies diversity
in RMs. In contrast to the SMs, the relative lack of sites under
strong selection in RMs at day 14 (Figure 3C) corroborates the
strong, early selection of a subset of variants from the SI. The
subsequent substantial increase (Figure 3D) in the number of
sites under selection and the magnitude of selection at those
sites not only reﬂect the outgrowth of variants more similar
to the SI, but also suggest the presence of immune-selective
pressures in the RMs during the postacute phase of infection.
To quantify the magnitude of selection in the SIVsm env
V1V2, cumulative dN and cumulative dS were calculated for
each animal at days 14 and 578 (Figure 3F). SMs and RMs
showed relative increases in cumulative dN and dS at day 578
(Wilcoxon rank sum test, p , 0.005), especially in a region of
V1 (amino acid positions 22–57) described as important in
antibody escape [25,28–30]. At later times, despite increases
of both dN and dS in RMs, cumulative dN-dS was greater in
RMs than SMs, although the difference was not statistically
signiﬁcant, suggesting greater positive selection pressures in
the non-natural host. However, continual evolution of V1V2
occurred in both species, consistent with observations of
persistent within-host positive diversifying selection in SMs
(unpublished data).
Variants Related to the Original Inoculum Reemerge in
RMs at Later Times Postinfection
Phylogenetic analyses of clones from day 100 p.i. showed
V1V2 sequences beginning to diversify in RMs, although the
variants remained clustered by host (Figure 4; see Figure S5
for parallel phylogenetic analysis of SM1). At this time, viral
sequences in RM1 were more closely related to variants from
the SI than to variants from 10 d p.i., suggesting a
reemergence of the SI-related quasispecies during chronic
infection. These results indicate that day 10 V1V2 variants are
an evolutionary ‘‘dead-end,’’ as it is unlikely that directional
evolution would result in viral quasispecies in all RMs that are
highly related to the original SI quasispecies.
At all time points after infection of the three SMs, average
nucleotide diversity of SIVsm V1V2 sequences remained
similar to that of the original SI (;3.0%; Figure 5). In
contrast, in RMs, nucleotide diversity increased after day 40
despite manifesting an initial restriction in viral diversity.
Viral variants at day 578 became more animal-speciﬁc
(unpublished data), as would be expected under host-speciﬁc
selection pressure. The viral diversity in RMs at day 578
(averaging 4.5% 6 0.8%) was greater than both that of the SI
and that of the SIVsm variants observed in SMs at late times
(t-test with Bonferroni adjustment, p ¼ 0.03). These data
suggest that selection pressures change during the course of
SIVsm infection of RMs; V1V2 variants that replicated to high
levels in primary infection lost their replicative advantage,
and previously undetected variants that were closely related
to the SI became detectable. The increasing nucleotide
diversity over time in RMs is consistent with the observed
increase in positive diversifying selection pressures in RMs
(see Figure 3).
No Early Selection for Specific gag Variants Following
Intra- or Cross-Species Transmission
Despite the high levels of selection in env, no species-
speciﬁc phylogenetic relationships were observed for SIVsm
gag variants at day 10 p.i. (Figure 6), indicating that there was
no preferential ampliﬁcation of speciﬁc gag variants in
association with the establishment of infection in either
SMs or RMs. The average nucleotide diversity of gag variants
following transmission to both species was similar to that of
the SI (unpublished data). These data suggest that most gag
variants were equivalent in their ability to establish successful
infection of either host. At later times, some amino acid
changes in gag became apparent in individual animals (Figure
S6). In both RMs analyzed at days 100 and 578, there was
almost complete amino acid ﬁxation at two sites (positions 39
and 68). Only one SM manifested any evidence of amino acid
ﬁxation in gag, and this was only partial (position 126 in SM2).
Fixation of amino acid changes, particularly at position 68,
which occurred in two RMs, could be due to cell-mediated
immune response pressures, which are thought to be stronger
in RMs compared to SMs [24]. However, that these changes
are due to random amino acid ﬁxation through genetic drift
cannot be ruled out, because of the large population sizes
involved and the limited number of gag clones analyzed.
Discussion
Identiﬁcation of speciﬁc characteristics that enable patho-
gens to infect new species may reveal why some emerging
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quasispecies diversity has been posited to underlie their
zoonotic success, yet no study had analyzed the behavior of
diverse naturally occurring viral quasispecies upon inocu-
lation into different host species. This study represents the
ﬁrst analysis, to our knowledge, of the evolution of a diverse
naturally occurring SIV quasispecies, following its side-by-
side inoculation into a new nonnatural host species (rhesus
macaques) and the natural host species from which it was
derived (sooty mangabeys). Our studies, which focused on the
intensive sequencing of large numbers of viral variants in the
env V1V2 region, point to the importance of diversity in this
region in initiating a successful cross-species infection event.
However, this does not exclude the possibility that diversity in
Figure 3. Evidence for Greater Positive Selection in SIV env at Later Times Postinfection
(A–E) Calculations for dN and dS were performed along the 124 amino acids of the V1V2 region using SNAP (http://hiv-web.lanl.gov/). The average dN
and dS at each codon is shown for SMs at day 14 (A) and day 578 (B), as well as for RMs at day 14 (C) and day 578 (D), and for the SI (E). Yellow boxes
indicate predicted N-gly sites, and asterisks indicate N-gly sites not present at early time points in RMs.
(F) Cumulative dN and dS are shown across all sites for each animal at day 14 and day 578. Raw values of cumulative dN and cumulative dS are
indicated below the graph.
DOI: 10.1371/journal.ppat.0010003.g003
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SIV Adaptation to a New Hostother genome regions, including diversity in other env
regions, plays an important role in cross-species transmission
events.
Upon inoculation of SMs with the diverse SIVsm quasis-
pecies, little host restriction was observed during acute
infection despite continued strong positive selection pres-
sures consistent with host-speciﬁc viral evolution and similar
to our ﬁndings in a study of natural infection in SMs
(unpublished data). However, a restricted, genetically related
subset of SIVsm env V1V2 variants that harbored a shorter V1
loop and lacked two speciﬁc glycosylation sites was prefer-
entially ampliﬁed in all of the RMs during acute infection.
This was observed despite IV inoculation, which would have
bypassed mucosal barriers, and was observed as early as 10
days p.i., likely prior to the development of immune
responses. While we cannot rule out that these variants
hitchhiked to a high frequency in the RMs, the observed
ampliﬁcation of a subset of variants appeared to represent an
advantage for these envelopes that was related to speciﬁc
features of target cells in the RM but not the SM. Loss of one
of these glycosylation sites (position 7) has been shown to
result in CD4-independent SIVs in the SIVmac239 strain [25],
suggesting the possibility that viral variants that preferen-
tially use CCR5 independently of CD4 may be selected for
during acute infection of the new RM host. It remains to be
determined whether loss of this same glycosylation site in
SIVsm also results in CD4 independence. Because CCR5 is
more highly conserved between SMs and RMs than is CD4
[31,32], it might be anticipated that CD4-independent viral
variants could overcome species differences in the primary
viral receptor (CD4) and have a distinct advantage in the new
host environment. The possibility that efﬁcient coreceptor
utilization independent of CD4 is an important factor in
establishing cross-species transmission is a topic for further
study.
Recently, the selection of more compact, glycan-restricted
HIV envs after heterosexual transmission was described
[16,17]. If the selection of slightly shorter, glycan-restricted
SIVsm envs observed in this study of cross-species trans-
mission is a related phenomenon, then, because our IV
inoculations bypassed mucosal barriers, the advantage of
such variants may be a posttransmission phenomenon. One
possibility is that in an antibody-naı ¨ve host environment,
more compact, less glycosylated Env conformations with
more accessible receptor-binding domains have a replicative
advantage. However, it is noteworthy that SIVsms encoding
less glycosylated V1V2 regions do not appear to have any
replicative advantage in newly infected, antibody-naı ¨ve SMs.
The lack of selective pressure on the SIVsm quasispecies in
acutely infected SMs suggests that highly glycosylated V1V2
variants are well adapted to initiate new infections of its
natural host species.
Although it might be expected that only a subset of SM-
adapted SIVs could replicate well in a new species, it is
intriguing that these variants replicated to levels exceeding
those seen in the natural SM host. In this [24] and other
studies of acute SIV infection [33,34], we have observed a
relationship between the magnitude of early CD4 T cell
activation and the magnitude of early virus replication. Given
the higher levels of CD4 T cell activation observed in the
Figure 4. Reemergence of Donor-Related Variants in Late Infection of
Nonnatural Hosts
ML tree of sequences from the SI and RM1 at days 10 and 100. Bootstrap
values greater than 50% are shown at nodes. The SI variants are
identified by the legend.
DOI: 10.1371/journal.ppat.0010003.g004
Figure 5. Temporal Changes in Nucleotide Sequence Evolution in SMs
and RMs
Mean pairwise nucleotide diversity of the V1V2 sequences for each
animal at each time point, calculated using the Tamura-Nei model of
nucleotide substitution in MEGA 2.1 [52]. The diversity of the SI is
indicated on the y-axis. Trend lines are drawn for RMs (red) and SMs
(blue).
DOI: 10.1371/journal.ppat.0010003.g005
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[24], it is conceivable that increased numbers of activated
CD4 T cells provided additional cellular targets for infection.
If this target cell-driven hypothesis of more robust SIVsm
replication in RMs is correct, it raises the possibility that SIV
infection-induced CD4 T cell activation in nonnatural hosts
actually facilitates zoonotic transmission of these CD4 T cell-
tropic lentiviruses. Additional studies are required to explore
this hypothesis. It is also worth noting that activated CD4 T
cells may up-regulate CCR5 (or other coreceptor) expression
[35], and down-regulate CD4 expression [36]. This might
provide another selective force for the observed glycan-
restricted SIVsm variants that may be less CD4 dependent in
newly infected RMs. Whatever the explanation for the
selection of speciﬁc env V1V2 variants in RMs, selection
pressures giving rise to these effects need not be strong, given
the high level of diversity of the inoculum and the likely
number of replication cycles involved. Nonetheless, the
robust replication of these variants ensured the establishment
of high viremia during infection of a new host, a character-
istic that would be important for continued propagation of
the virus in the new species.
At later times p.i. of RMs, SIVsm variants more closely
related to the original SI quasispecies reemerged, suggesting
that all variants were initially transmitted to the RMs, but that
only a subset of variants replicated to high levels during the
acute infection period. Variants related to the SI may have
been physically sequestered in resting memory cells, as has
been suggested for HIV-1 [37], or simply replicated at such
low levels that they were not sampled. Studies have suggested
that ‘‘archival’’ HIV variants are maintained in infected hosts
[38]. When host selection pressures change, such as with the
termination of antiretroviral therapy, these archived variants
may emerge, obviating the necessity for back mutation of the
most predominant viral variants at the time of change in
selection pressure. This capacity to archive the variants
present in a diverse, infecting swarm, referred to as the
‘‘molecular memory’’ of the quasispecies [39], demonstrates
the signiﬁcant potential of lentiviral quasispecies to respond
to changing selection pressures and presents signiﬁcant
hurdles when considering HIV prevention or treatment
measures. SI V1V2 variant emergence at later times suggests
that these viruses have replicative advantages in chronically
infected RMs, perhaps due to their resistance to neutralizing
antibodies. Compensatory changes in other regions of the
genome (e.g., in the CD4-binding region of SIV env) could
also have relieved initial selection pressures against these
variants.
This study demonstrates how viral quasispecies diversity
enables successful cross-species transmission by providing
multiple variants, some of which are able to establish high-
level viremia in new hosts, which, in turn, increases the
probability of successful propagation within new species. Our
studies point to SIVsm env diversity in its reservoir host as a
likely required, although not necessarily sufﬁcient prereq-
uisite for successful cross-species transmission. These obser-
vations have implications for which infectious agents may be
zoonotically transmitted and efﬁciently propagated in a new
host species. Finally, the potential roles of CD4-independent
SIVs and coreceptor sequence conservation in cross-species
transmission are important topics for further study.
Figure 6. Phylogenetic Analysis of SIVsmm gag Variants in Natural and Nonnatural Hosts
An NJ unrooted phylogenetic tree of all day-10 gag variants was constructed in PAUP* [43] using the GTR model with a gamma rate distribution of
shape a¼1.0. The SI variants are represented by triangles and identified by the legend. Bootstrap values greater than 50% are shown at nodes, and the
number of multiple clones from the same animal at the ends of branches is indicated within the symbol.
DOI: 10.1371/journal.ppat.0010003.g006
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Experimental SIV infection. SMs and RMs were housed at the
Yerkes National Primate Research Center, Atlanta, Georgia, United
States, and maintained in accordance with federal guidelines [40].
Prior to the study, the absence of SIV infection was conﬁrmed by
negative SIV PCR of plasma and negative HIV-2 serology for at least 1
y. Three RMs and three SMs were experimentally infected IV with a
diverse inoculum of uncloned SIVsm from a naturally infected SM
(individual FQi). SMs FLn, FCo, and FGu are referred to as SM1, SM2,
and SM3, respectively. RMs RHt4, RQl4, and RZw4 are referred to as
RM1, RM2, and RM3, respectively. The animals were followed at
multiple time points following the infection, and quantitative PCR
was carried out to determine the viral dynamics of their acute SIV
infection [24].
PCR. Viral RNA was extracted from freshly thawed plasma samples
from the three SMs and three RMs in this study using the Qiagen
Viral RNA Kit. SIV sequences were ampliﬁed from 5 lL of template
in a PCR reaction using the Qiagen One-Step RT-PCR Kit (Qiagen,
Valencia, California, United States).
To amplify the env V1V2 region, a mixture of two forward primers
was used, FENV1 (59-CTTGGGAGAATACAGTCACAG-39) corre-
sponding to bp 6,780–6,800 of the SIVsmmH4 genome, and FENV2
(59-CTTGGGAGAATACAGTAACAG-39) also corresponding to bp
6,780–6,800 but containing one different base at position 6,796. The
reverse env V1V2 primer was also a mixture of RENV1 (59-
TAAATCTAATAGCATCCCAATAAT-39) and RENV2 (59-TAAATC-
TAATAGCATCCCAATAGT-39) corresponding to bp 7,221–7,244 of
the SIVsmmH4 genome, and differing at bp 7,222. The primer pair
ampliﬁed a 456-bp fragments spanning the V1V2 hypervariable
region of env.
The gag region was ampliﬁed using shortgagF1 (59-TTAAGTC-
CAAGAACATTAAATGC-39) and shortgagR (59-GTAGAACCTGTC-
TACATAGCT-39), which correspond to bp 1,493–1,515 and 1,937–
1,957 of SIVsmmH4, respectively, yielding a 421-bp product of the 59
end of the p27 capsid protein.
Conditions for each reaction were 30 min at 50 8C and 15 min at 95
8C, followed by 40 cycles of 94 8C for 1 min, 52 8C for 30 s, and 72 8C
for 1 min. A ﬁnal extension time was carried out for 5 min at 72 8C.
Due to extremely low viral load, RNA from RM2 could not be
ampliﬁed after day 14 for either V1V2 or gag. RT-PCR sensitivity was
determined to be less than 500 copies per reaction. Viral loads from
each of the animals did not signiﬁcantly differ at each time point
(with the exception of animal RM3, in which virus was undetectable
using the RT-PCR protocol after day 14). Samples were not
standardized for input copy number, potentially confounding the
extent of change in viral diversity that was measured over time,
although this would not confound comparisons between animals at
each time point since viral loads were similar.
No-template controls and negative controls from the RNA
extraction were used in each set of reactions to ensure that no
cross contamination occurred at either step. In addition, samples
from each pair of animals, SM1/RM1, SM2/RM2, SM3/RM3 were
extracted at least 3 mo apart. This ensured that contamination
within species was avoided. Contamination of negative-extraction
controls was detected when extracting SM2 and RM2 samples from
days 70 and 100. This extraction was repeated, and virus could not
be ampliﬁed from RM2 due to very low copy numbers. On one
occasion, the RT-PCR reaction was contaminated with a particular
molecular clone, however these sequences were easy to identify with
phylogenetic analysis due to their extensive divergence from the SI.
These contaminants were excluded from the analysis. RNA
extracted from day 10 plasma in SM1 and RM1 was RT-PCR
ampliﬁed under the same conditions as above, except that 10 lLo f
PCR product was removed at 25, 30, 35, and 40 cycles for cloning
and sequencing to ensure that PCR bias during extended cycling
was not a factor in sample diversity. Viral RNA from days 70 and
100 for RM1 and RM3 was extracted, PCR ampliﬁed, and cloned in
duplicate to ensure experimental repeatability. A 1:10 dilution of SI
was ampliﬁed under the same conditions, and 15 clones from this
RT-PCR product were sequenced to ensure that input copy number
did not bias diversity.
DNA cloning and sequencing. PCR products from each sample
were run on a 1.5% low-melt agarose gel, and the 456-bp V1V2 or
421-bp gag product was extracted and cloned into the pCR4-TOPO
vector (TOPO TA Cloning Kit, Invitrogen, Carlsbad, California,
United States). Between 15 and 30 V1V2 clones and 5 and 10 gag p27
clones from each time point and each animal were randomly selected
and sequenced using the M13F and M13R primers with the dye
terminator cycle sequencing method.
Sequence and phylogenetic analyses. Sequences were aligned using
the program CLUSTAL X [41], followed by manual adjustment using
MacClade 4.0 [42]. Nonaligned regions of length variation in V1 and
V2 were removed (corresponding to nucleotides 6,932–6,974), and
sequences containing internal stop codons, single deletions, or
double deletions were also excluded from analysis, as these are
thought to be PCR artifacts [43]. Figures S1 and S2 show the resulting
alignment of all sequences in V1V2 and gag, respectively.
For the SI, maximum parsimony and NJ were implemented using
the PAUP 4.0b10* package for V1V2 and gag [44]. For each of the
resulting trees, bootstrap support was determined with 1,000
resamplings of the sequences. The most highly supported clade in
both the NJ and the parsimony trees was used as the outgroup for all
subsequent phylogenetic trees (Figure S3).
For tree construction, the Modeltest program [45] was used to
construct and evaluate the DNA substitution models used. Based on
the Modeltest results, phylogenetic analysis on sequences obtained
from successive time points during the acute infection was performed
by ML using the program Treeﬁnder [46]. The general time reversible
(GTR) model, which allows for rate variation between sites [47–49],
was used, and the shape parameter (a) of the gamma distribution used
in this model was estimated, as were base frequencies and
substitution rate parameters. Bootstrap support was determined with
1,000 resamplings of the ML tree using distance methods in
PAUP4.0b10*, incorporating the estimated rate parameters.
The cumulative number of synonymous and nonsynonymous and
nucleotide substitutions was estimated using Synonymous/Nonsynon-
ymous Analysis (SNAP; http://hiv-web.lanl.gov/), which calculates rates
of nucleotide substitution from a set of codon-aligned nucleotide
sequences, based on the method of Nei and Gojobori [50], and
incorporating a statistic developed in Ota and Nei [51]. Viral
nucleotide diversity at each time point was determined by calculating
the pairwise nucleic acid distances for each of the clones using the
method of Tamura and Nei [52] in the program MEGA 2.1 [53]. This
same method was also employed to quantify nucleotide divergence
from the source, deﬁned as the ratio of the difference in nucleotide
diversity between SI and each sample of variants to the total diversity
in the two groups. Amino acid diversity was calculated using the
gamma distance method in the program Mega 2.1. Phylogenetic trees
constructed with synonymous or nonsynonymous sites only were
constructed in Mega 2.1 using distance methods incorporating the
Tamura-Nei model of nucleotide substitution with gamma-distrib-
uted rates. All statistics were computed using SYSTAT 10 software
(SPSS, Chicago, Illinois, United States).
Supporting Information
Figure S1. Phylogenetic Analysis of Source Inoculum V1V2 Variants
with Molecular Clones
(A) NJ tree showing the most highly supported clade of SI used as the
outgroup for all subsequent phylogenetic trees. (B) An unrooted ML
tree of 30 SI V1V2 variants and corresponding V1V2 sequences from
clones SIVmac239, SIVsmmH4, and SIVmne (obtained from the HIV
sequence database [http://hiv-web.lanl.gov/content/index]) was con-
structed with Treeﬁnder [46] using a GTR model and estimated
gamma rate distribution, base frequencies, and substitution rates.
Bootstrap values greater than 50% are shown at nodes.
Found at DOI: 10.1371/journal.ppat.0010003.sg001 (53 KB PDF).
Figure S2. Viral Replication Dynamics following Infection with a
Diverse SIVsmm
Three SMs and three RMs were inoculated with plasma obtained from
a naturally infected SM. Viral replication was monitored in SMs and
RMs by quantitative RT-PCR of plasma RNA (see Materials and
Methods).
Found at DOI: 10.1371/journal.ppat.0010003.sg002 (210 KB PDF).
Figure S3. Amino Acid Sequences of All Animals and All Time Points
in the V1V2 Region of Envelope
Region corresponds to nucleotides 6,801–7,220 of SIVsmmH4.
Sequences were aligned using the program CLUSTAL X [41],
followed by manual adjustment using MacClade 4.0 [42]. A non-
aligned region of length variation in V1 was removed, corresponding
to amino acids 129–137 of SIVsmmH4 env, and is indicated by ‘‘;’’.
The consensus of all sequences in this study is shown above all sample
sets, with codon positions labeled above. A dot indicates amino acid
identity with the consensus sequence, and any amino acid changes are
indicated with the appropriate symbol. The V1V2 regions are
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consensus motifs present in each sequence are highlighted in yellow.
Found at DOI: 10.1371/journal.ppat.0010003.sg003 (226 KB DOC).
Figure S4. Mean Number of Glycosylation Consensus Motifs in SMs
and RMs for All Time Points
Frequency of glycosylation consensus motifs is lower in RMs
(regression analysis, p , 0.001) and increases over time in both SMs
and RMs. The number of motifs in the SI is indicated with a star on
the y-axis.
Found at DOI: 10.1371/journal.ppat.0010003.sg004 (114 KB PDF).
Figure S5. Phylogenetic Analysis of Natural Host V1V2 Variants at
Days 10–100 Shows No Speciﬁc Pattern
ML phylogenetic tree of sequences obtained from SM1 at days 10
(pink) to 100 (red) is shown, constructed with Treeﬁnder [46] using a
GTR model and estimated gamma rate distribution, base frequencies,
and substitution rates. Bootstrap values greater than 50% are shown
at nodes, and the number of multiple clones from the same animal at
the ends of branches is indicated within the symbol. The SI variants
are represented by triangles and identiﬁed by the label within.
Found at DOI: 10.1371/journal.ppat.0010003.sg005 (77 KB PDF).
Figure S6. Amino Acid Sequences of All Animals and All Time Points
in the p27 Region of gag
Region corresponds to nucleotides 1,516–1,936 of SIVsmmH4.
Sequences were aligned using the program CLUSTAL X [41],
followed by manual adjustment using MacClade 4.0 [42]. The top
sequence in each set corresponds to the majority consensus sequence
from all sequences at all time points, with codon positions labeled
above. A dot indicates amino acid identity with the consensus
sequence, and any amino acid changes are indicated with the
appropriate symbol.
Found at DOI: 10.1371/journal.ppat.0010003.sg006 (75 KB DOC).
Accession Number
The GenBank (http://www.ncbi.nlm.nih.gov/) accession number of
the SIVsmmH4 genome is X14307.
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